AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie net Revenues by Country — Annual Geographic Disaggregation ($M) ($M)
Form 10-K Note 16 Segment & Geographic Information
Latest, FY2025
61,160
Period ended Dec 31, 2025
Change on a year earlier
+8.6%
56,334 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Revenues by Country — Annual Geographic Disaggregation ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 61,160 | +8.6% | Form 10-K (filed 2026-02-20) ↗ |
| FY2024 | Dec 31, 2024 | 56,334 | +3.7% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 54,318 | -6.4% | Form 10-K (filed 2026-02-20) ↗ |
| FY2022 | Dec 31, 2022 | 58,054 | +3.3% | Form 10-K (filed 2025-02-14) ↗ |
| FY2021 | Dec 31, 2021 | 56,197 | +22.7% | Form 10-K (filed 2024-02-20) ↗ |
| FY2020 | Dec 31, 2020 | 45,804 | +37.7% | Form 10-K (filed 2023-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 33,266 | +1.6% | Form 10-K (filed 2022-02-18) ↗ |
| FY2018 | Dec 31, 2018 | 32,753 | +16.1% | Form 10-K (filed 2021-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 28,216 | +10.1% | Form 10-K (filed 2020-02-21) ↗ |
| FY2016 | Dec 31, 2016 | 25,638 | +12.2% | Form 10-K (filed 2019-02-27) ↗ |
| FY2015 | Dec 31, 2015 | 22,859 | – | Form 10-K (filed 2018-02-16) ↗ |
Breakdown
What makes up net revenues by country — annual geographic disaggregation ($m)
- United States ($M)46,603 · FY2025
- Germany ($M)1,738 · FY2025
- Japan ($M)1,274 · FY2025
- Canada ($M)1,222 · FY2025
- China ($M)1,006 · FY2025
- France ($M)806 · FY2025
- United Kingdom ($M)626 · FY2025
- Spain ($M)609 · FY2025
- Italy ($M)580 · FY2025
- Brazil ($M)478 · FY2025
- Australia ($M)459 · FY2025
- All Other Countries ($M)5,759 · FY2025
- Netherlands [legacy through FY19] ($M)163 · FY2019
Cite this data
StockData. (2026). AbbVie Net Revenues by Country — Annual Geographic Disaggregation ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/geo_country_rev_total
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.